CDK4 and hepatocellular carcinoma: According to previous reports, CDK4/Cyclin D1 can phosphorylate the Ser249 of p53-RS, enhancing the binding of p53-RS and c-Myc, it can thereby activating the c-Myc transcription pathway, and promoting the growth of HCC cells [58].